Table Of Contents

1. Introduction
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Hemostats Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered
2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Source
2.8. Assumptions
3. Market Overview
3.1. Drivers
3.1.1. Chronic Conditions And Aging Population Leading To Increase In Number Of Surgical Procedures
3.1.2. Technological Advancements
3.1.3. Increasing Number Of Minimally Invasive Surgeries
3.1.4. Improving Healthcare Infrastructure And Increasing Healthcare Spending
3.2. Restraints
3.2.1. Reluctance Of Surgeons Towards New Products
3.2.2. Weak Reimbursement
3.3. Opportunities
3.3.1. Unmet Medical Needs
3.3.2. Emerging Market
3.4. Challenges
3.4.1. Development Of Substitute Products
3.4.2. Limitations Of Hemostatic Agents In Achieving Hemostasis
4. Premium Insights
5. Regulatory
5.1. Overview
5.2. Regulatory Procedure
6. Reimbursement
6.1. Overview
6.2. Reimbursement Scenario
7. Executive Summary
8. Global Hemostats Market, By Type
8.1. Overview
8.2. Thrombin Based Hemostats
8.3. Combination Agent Hemostats
8.4. Oxidized Regenerated Cellulose Based Hemostats
8.5. Gelatin Based Hemostats
8.6. Collagen Based Hemostats
9. Global Hemostats Market,By Application
9.1. Overview
9.2. Global Hemostats Market, By Application
9.3. Wound Closure
9.4. Surgical Hemostats
?
10. Global Hemostats Market, By Distribution Channel
10.1. Overview
10.1.1. Direct Tenders
10.1.2. Retail
11. Global Hemostats Market, By End User
11.1. Overview
11.2. Hospitals
11.3. Ambulatory Centers
11.4. Community Healthcare
11.5. Clinics
12. Global Hemostats Market, By Geography
12.1. Overview
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.2.3. Mexico
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Russia
12.3.7. Turkey
12.3.8. Belgium
12.3.9. Netherlands
12.3.10. Switzerland
12.3.11. Rest Of Europe
?
12.4. Asia-Pacific (Asia-Pacific)
12.4.1. Japan
12.4.2. China
12.4.3. South Korea
12.4.4. India
12.4.5. Australia
12.4.6. Singapore
12.4.7. Thailand
12.4.8. Malaysia
12.4.9. Indonesia
12.4.10. Philippines
12.4.11. Rest Of Asia-Pacific
12.5. South America
12.5.1. Brazil
12.5.2. Rest Of South America
12.6. Mea
12.6.1. South Africa
12.6.2. Rest Of Mea
13. Global Hemostats Market, Company Landscape
13.1. Company Share Analysis; Global
13.2. Company Share Analysis; North America
13.3. Company Share Analysis; Europe
13.4. Company Share Analysis; Asia-Pacific
14. Company Profiles
14.1. Ethicon Us, Llc (Subsidiary Of Johnson &
Johnson Services, Inc)
14.1.1. Company Overview
14.1.2. Revenue Analysis
14.1.3. Product Portfolio
14.1.4. Recent Developments
14.2. Pfizer
14.2.1. Company Overview
14.2.2. Revenue Analysis
14.2.3. Product Portfolio
14.2.4. Recent Developments
14.3. C.R Bard
14.3.1. Company Overview
14.3.2. Revenue Analysis
14.3.3. Product Portfolio
14.3.4. Recent Developments
14.4. Baxter
14.4.1. Company Overview
14.4.2. Revenue Analysis
14.4.3. Product Portfolio
14.4.4. Recent Developments
14.5. Vascular Solutions, Inc
(Acquired By Teleflex Incorporated)
14.5.1. Company Overview
14.5.2. Revenue Analysis
14.5.3. Product Portfolio
14.5.4. Recent Developments
14.6. B.Braun Melsungen Ag
14.6.1. Company Overview
14.6.2. Revenue Analysis
14.6.3. Product Portfolio
14.6.4. Recent Developments
?
14.7. 3-D Matrix Ltd
14.7.1. Company Overview
14.7.2. Revenue Analysis
14.7.3. Product Portfolio
14.7.4. Recent Developments
14.8. Resorba Medical Gmbh
14.8.1. Company Overview
14.8.2. Revenue Analysis
14.8.3. Product Portfolio
14.8.4. Recent Developments
14.9. Anika Therapeutics, Inc.
14.9.1. Company Overview
14.9.2. Revenue Analysis
14.9.3. Product Portfolio
14.9.4. Recent Developments
14.10. Biom?Up
14.10.1. Company Overview
14.10.2. Revenue Analysis
14.10.3. Product Portfolio
14.10.4. Recent Developments
14.11. Cryolife, Inc.
14.11.1. Company Overview
14.11.2. Revenue Analysis
14.11.3. Product Portfolio
14.11.4. Recent Developments
14.12. Equimedical
14.12.1. Company Overview
14.12.2. Revenue Analysis
14.12.3. Product Portfolio
14.12.4. Recent Developments
14.13. Hemostasis, Llc
14.13.1. Company Overview
14.13.2. Revenue Analysis
14.13.3. Product Portfolio
14.13.4. Recent Developments
14.14. Medtrade Products Limited
14.14.1. Company Overview
14.14.2. Revenue Analysis
14.14.3. Product Portfolio
14.14.4. Recent Developments
14.15. Stryker
14.15.1. Company Overview
14.15.2. Revenue Analysis
14.15.3. Product Portfolio
14.15.4. Recent Developments
14.16. Arch Therapeutics, Inc.
14.16.1. Company Overview
14.16.2. Revenue Analysis
14.16.3. Product Portfolio
14.16.4. Recent Developments
14.17. Integra Lifesciences Corporation
14.17.1. Company Overview
14.17.2. Revenue Analysis
14.17.3. Product Portfolio
14.17.4. Recent Developments
?
14.18. Altaylar Medical
14.18.1. Company Overview
14.18.2. Revenue Analysis
14.18.3. Product Portfolio
14.18.4. Recent Developments
14.19. Biocer Entwicklungs-Gmbh
14.19.1. Company Overview
14.19.2. Revenue Analysis
14.19.3. Product Portfolio
14.19.4. Recent Developments
14.20. Smi (Starch Medical)
14.20.1. Company Overview
14.20.2. Revenue Analysis
14.20.3. Product Portfolio
14.20.4. Recent Developments
15. Related Reports